期刊文献+

生长激素对胰腺癌IGF-Ⅰ,Ⅱ-IGFBP3通路动态影响的实验研究 被引量:2

Effect of growth hormone on features of IGF-Ⅰ-Ⅱ-IGFBP3 pathway in pancreatic cancer
原文传递
导出
摘要 目的 观察生长激素(GH)对胰腺癌细胞增殖及对肿瘤宿主胰岛素样生长因子Ⅰ,Ⅱ(IGF-Ⅰ,Ⅱ)-胰岛素样生长因子结合蛋白3(IGFBP3)通路的影响,初步探讨体内外实验差异的原因.方法 体外应用GH(50 ng/ml)24 h,48 h,72 h后计数胰腺癌细胞SW-1990,PANC-1及P3;选用BALB/C雌性裸小鼠35只,以SW-1990成瘤,测量瘤体积,成瘤裸鼠随机分为注射GH的实验组(GH组)及对照组(NS组),荷瘤裸鼠在最后依次注射GH后第1小时、2小时、6小时及24小时处死动物,心室穿刺抽血,切除肝脏,酶联免疫吸附法(ELISA)检测血清IGF-Ⅰ,-Ⅱ水平(P<0.05),蛋白印记(Western Blot)方法观察肝脏IGFBP3的相对光密度(ROD)变化.结果 GH在体外可加速胰腺癌细胞增殖但在体内不促进肿瘤生长;GH上调荷瘤宿主血清IGF-Ⅰ、Ⅱ水平;与GH刺激前(NS)相比,肝脏IGFBP3表达在GH刺激后1 h、2 h、6 h有显著提高(P<0.05),24 h有所减弱.结论 GH对胰腺癌细胞的作用存在一定的体内外差异;GH在体内通过提高IGF-Ⅰ、Ⅱ水平发挥效应,GH不刺激在体肿瘤生长可能与IGFBP3上调有关. Objective To investigate the effect of GH on proliferation of pancreatic cancer cells and observe the features of IGF-IGFBP3 pathway in the host after GH administration. Methods Pancreatic cancer cells (SW-1990,PANC-1 and P3) during exponential growth stage were harvested and cultured in medium containing growth hormone (50 ng/ml). After 24, 48 and 72 hours, cells were counted using a Coulter Counter. Thirty-five Athymic nude Balb/c mice were inoculated with SW-1990cells. When tumors became palpable after inoculation, animals were randomized to receive GH points (1 h, 2 h, 6 h, 24 after the last injection), plasma samples were gathered for subsequent ELISA determination and liver was rapidly incised for immune blotting analysis. Results The results revealed that GH stimulated cell growth in vitro. GH elevated levels of IGF-Ⅰ , Ⅱ at the 1st , 2nd , 6th hour after the last injection. GH augmented the expression of IGFBP3 in the liver of the host in vivo (1 h, 2 h, 6 h, 24 h, respectively). Conclusion Such proteins as IGF- Ⅰ and Ⅱ might be associated with mechanism of last effect of GH on tumor host. The up-regulation of IGFBP3 by GH administration in the host may help to explain the phenomena that GH doesn't accelerate growth of pancreatic tumor in vivo.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2010年第6期435-438,共4页 Chinese Journal of Hepatobiliary Surgery
基金 江苏省"135"基金重点资助项目(08)
关键词 胰腺肿瘤 生长激素 胰岛素样生长因子Ⅰ 胰岛素样生长因子Ⅱ 胰岛素样生长因子结合蛋白3 Pancreatic neoplasms Growth hormone Insulin-like growth factor-Ⅰ Insulin-like growth factor-Ⅱ Insulin-like growth factor binding proteino-3
  • 相关文献

参考文献10

  • 1Ezaduar F,Van-Tol HT,Colenbrander B.Stimulatory effect of growth hormone on in vitro mataration of bovine oocytes is exerted through cumulus cells and not mediated by IGF-Ⅰ.Mol Reprod Dev,1997,47:175-180.
  • 2Yakar S,Leroith D,Brodt P.The role of the growth hormone/insulin-like growth factor axis in tumor growth and progreysion:Lessons from animal models.Cytokine Growth Factor Rev,2005,16:407-420.
  • 3Packer RJ,Boyett JM,Janss AJ,et al.Growth hormone replacement therapy in children with medulloblastoma:use and effect on tumor control.J Clin Oncol,2001,19:480-487.
  • 4石毅,赵玉沛,廖泉,苗毅.生长激素受体在胰腺癌-慢性胰腺炎导管细胞的表达及生长激素对移植瘤PCNA的影响[J].中华肝胆外科杂志,2007,13(12):840-843. 被引量:1
  • 5Kaneda A,Wang CJ,Cheong R,et al.Enhanced sensitivity to IGF-Ⅱ signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.Proc Natl Acad Sci USA,2007,104:20926-20931.
  • 6Monzavi R,Cohen P.IGFs and IGFBPs:role in health and disease.Clin Endocrinol Metab,2002,16:433-447.
  • 7Choiand HK,Waxman DJ.Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling:developmental regulation and role in male-specific liver gene expression.Endocrinology,2000,141:3245-3255.
  • 8Aishima S,Basaki Y,Oda Y,et al.High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.Cancer Sci,2006,97:1182-1190.
  • 9Takaoka M,Kim SH,Okawa T,et al.IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.Cancer Biol Ther,2007,6:534-540.
  • 10Torng PL,Lee YC,Huang CY,et al.Insulin-like growth factot binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma.Oncogene,2008,27:2137-2147.

二级参考文献9

  • 1David T, Lincoln, Hans E, et al. Growth hormone and colorectal carcinoma: localization of recepters. In Vivo, 2000, 14: 41-50.
  • 2Swerdlow AJ. GH, IGF-1, and the risk of cancer, an epidemiological perspective. Growth Hormone IGF Res, 2001, 11: 337-342.
  • 3Kohn DT, Kopchick JJ. Growth hormone receptor antagonists. Minerva Endocrinol, 2002, 27: 287-298.
  • 4Peter E, Christoher T. Safety issues in children and adolescents during growth hormone therapy-a review. Growth Hormone IGF Res, 2000, 10, 306-317.
  • 5Garcia-Caballero T, Mertani HM, Lambert A. Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas. Endocrine, 2000, 12: 265-271.
  • 6Martha PM, Reiter EO, Davila N, et al. Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. J Clin Endocr Metab, 1992, 75: 1464-1497.
  • 7Lorenzo GD, Bianco R, Tortora G, et al. Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence. Clin Prostate Cancer, 2003, 2: 50-57.
  • 8Rico E, Negrin C, Novoa J, et al. Downregulation of the growth hormone-induced Janus kinase 2/signal transducerand activator of transcription 5 signaling pathway requires an intact actin. Exp Cell Res, 2004, 294: 269-280.
  • 9Hookes P. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am J Pathol, 1991, 138: 1165-1167.

同被引文献19

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部